Xylem Q3 2026 earnings
Revenue down 3% YoY, but EPS up 34% and adjusted EBITDA margin up 70 bps driven by productivity and price realization.
Headline numbers
| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---|---|---|
| Revenue | $2.20B | -3% | — | Ex. 99.1, income statement |
| EPS (GAAP) | $1.25 | +34% | — | Ex. 99.1, income statement |
| EPS (adjusted) | $1.44 | +5% | — | Ex. 99.1, income statement |
| Net income | $291M | +28% | — | Ex. 99.1, income statement |
| Adj. EBITDA | $527M | +2% | — | Ex. 99.1, income statement |
| Adj. EBITDA margin | 23.9% | +70 bps | — | Ex. 99.1, income statement |
Revenue breakdown
not stated in the 8-K
Margins and costs
- Gross margin 41.2% (prior 39.0%, change +2.2 pp)
- Operating expenses $514M (+7% YoY)
- One-offs in the quarter Loss on sale of businesses $5M (vs $37M in Q3 2025); Restructuring and asset impairment charges $8M; Special charges $23M (includes IEEPA tariff refunds)
- Effective tax rate 21.1% (prior-year 21.2%, year-to-date 24.1%)
- Non-GAAP bridge Adds back purchase accounting intangible amortization, loss on sale of businesses, restructuring and realignment costs, and special charges (including IEEPA tariff refunds).
KPIs
| Metric | Actual | Prior quarter | Prior year | Change |
|---|---|---|---|---|
| Orders | $2.30B | — | — | +7% reported, +10% organic |
| Backlog | — | — | — | — |
| Free cash flow margin | 10.2% | — | — | — |
Guidance
| Metric | Guide | Prior guide | Change |
|---|---|---|---|
| Full-year 2026 Revenue | Approximately $8.95B | Up 2% YoY | Down 1% YoY |
| Full-year 2026 Adjusted EBITDA margin | Approximately 23.2% | — | +100 bps vs 2025 |
| Full-year 2026 Adjusted EPS | $5.40 to $5.45 | $5.55 to $5.70 | Down from prior range |
| Full-year 2026 Free cash flow margin | Approximately 10.2% | 10.2% to 11.0% | Down from prior range |
What drove it
- Revenue story Revenue down 3% YoY due to project timing and cautious spending, but orders up 7% reported and 10% organically.
- EPS story EPS up 34% YoY driven by strong operational performance and lower loss on sale of businesses, partially offset by increased interest and tax expense.
- One-off check Loss on sale of businesses $5M (vs $37M in prior year); Special charges $23M (includes IEEPA tariff refunds).
The good
- Orders up 7% reported and 10% organically
- Adjusted EBITDA margin up 70 bps YoY driven by productivity and price realization
- Net income margin increased 320 bps to 13.2%
The bad
- Revenue down 3% YoY due to project timing and cautious spending environment
- Full-year 2026 revenue guidance cut from up 2% to down 1% YoY
- Full-year 2026 adjusted EPS guidance cut from $5.55-$5.70 to $5.40-$5.45
The ugly
- none
Open questions
- Impact of the planned divestiture of Applied Water International and Specialty Flow Control on 2026 results
- Specific drivers of the 1% revenue decline in the full-year outlook vs prior guidance
- Details on the 'special charges' including IEEPA tariff refunds
Full release
Earnings: XYL — filed 2026-10-27
Xylem Inc.
301 Water Street SE, Suite 200
Washington, DC
20003
Tel +1.202.869.9150
Xylem Reports Third Quarter 2026 Results and Announces
Strategic Actions to Accelerate Growth
• Strong orders and backlog, solid earnings performance and margin expansion reflect operational excellence despite a more cautious spending environment
• Company accelerates transformation strategy, announces intent to divest Applied Water International and Specialty Flow Control; and move to three segment structure in 2027
WASHINGTON, D.C.,
October 27, 2026 – Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today reported third-quarter 2026 results and announced actions to further accelerate its portfolio transformation.
While revenue was impacted by project timing and more cautious spending decisions, strong order activity and solid earnings performance demonstrated the resilience of the business and the benefits of the company’s transformation. Xylem also announced its intent to divest Applied Water International and Specialty Flow Control, and beginning in 2027, the alignment of its businesses from four segments to three.
Third Quarter Results
Highlights:
• Orders of $2.3 billion, up 7% on a reported basis and 10% organically
• Revenue of $2.2 billion, down 3% on a reported basis and flat organically
• Earnings per share of $1.25, up 34%; $1.44 on an adjusted basis, up 5%
Third quarter results reflected a mixed operating environment. The company delivered total revenue of $2.2 billion against a dynamic backdrop. Third-quarter earnings per share were up 34 percent on a reported basis and 5 percent on an adjusted basis.
Net income attributable to Xylem for the quarter was $291 million, or $1.25 per share. Net income margin increased 320 basis points to 13.2 percent. These results are primarily driven by strong operational performance and lower loss on sale of businesses, partially offset by increased interest and income tax expense. Adjusted net income attributable to Xylem was $336 million, or $1.44 per share, which excludes purchase accounting intangible amortization, loss on sale of businesses, restructuring and realignment costs, and special charges, including the impact of IEEPA tariff refunds.¹
Third-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 23.9 percent, reflecting a year-over-year increase of 70 basis points. Productivity savings and strong price realization drove the margin expansion, exceeding the impact of inflation, lower volumes, and mix.
Outlook
Xylem now forecasts full-year 2026 revenue of approximately $8.95 billion, down 1 percent year over year on a reported basis, versus prior guidance of up 2 percent, and flat on an organic basis, versus prior guidance of up 2 to 3 percent.
Full-year 2026 adjusted EBITDA margin is expected to be approximately 23.2 percent, an increase of 100 basis points versus Xylem’s 2025 adjusted results. This results in full-year adjusted earnings per share of $5.40 to $5.45, down from the previous guidance range of $5.55 to $5.70. Full-year free cash flow margin is expected to be approximately 10.2 percent, versus 10.2 to 11.0 percent previously guided.
Further 2026 planning assumptions are included in Xylem’s third-quarter 2026 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.
Supplemental information on Xylem’s third-quarter earnings, as well as definitions of and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.
Sharpening Xylem’s Focus for Growth
Xylem's planned divestiture of Applied Water International and Specialty Flow Control and its move to a three-segment structure are designed to create a more focused company aligned around customer needs and long-term growth priorities.
The planned divestitures further sharpen Xylem’s focus, enabling the company to direct capital toward the technologies, capabilities and markets that align most closely with its long-term strategy. Xylem is already seeing momentum in high-growth industry verticals, including data centers and microelectronics, reinforcing the opportunity to increase investment and exposure in these markets.
Beginning January 1, 2027, Xylem will align its business into three segments: Treatment and Services, Flow Solutions, and Measurement and Analytics. The new structure brings together complementary technologies and capabilities around the core activities of moving water, treating water, and measuring and optimizing water systems. By bringing together businesses with shared customers, technologies and growth opportunities, Xylem expects to unlock greater value across the portfolio and operate with greater simplicity, speed and accountability. Treatment and Services will be led by Rodney Aulick; Flow Solutions will be led by Joe Johnston; and Measurement and Analytics will be led by Meredith Emmerich.
“We’re moving with urgency to shape Xylem around the markets where our capabilities can deliver the greatest customer value and strongest long-term growth," said Matthew Pine, president and CEO of Xylem. "The resilience we’ve built, evident this quarter, allows us to make those choices deliberately and from a position of strength.”
###
About Xylem
Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water.²
Xylem uses our Investor Relations website, www.xylem.com/investors... (truncated)r material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media.
Financial statements
Income Statement
Three Months — CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) (in millions, except per share data)
| Three Months – 2026 | Three Months – 2025 | Nine Months – 2026 | Nine Months – 2025 | ||
|---|---|---|---|---|---|
| Revenue from products | 1,807 | 1,867 | 5,517 | 5,487 | |
| Revenue from services | 394 | 401 | 1,145 | 1,151 | |
| Revenue | 2,201 | 2,268 | 6,662 | 6,638 | |
| Cost of revenue from products | 1,026 | 1,109 | 3,176 | 3,279 | |
| Cost of revenue from services | 268 | 276 | 813 | 816 | |
| Cost of revenue | 1,294 | 1,385 | 3,989 | 4,095 | |
| Gross profit | 907 | 883 | 2,673 | 2,543 | |
| Selling, general and administrative expenses | 458 | 474 | 1,433 | 1,437 | |
| Research and development expenses | 56 | 52 | 171 | 166 | |
| Restructuring and asset impairment charges | 8 | 23 | 50 | 70 | |
| Operating income | 385 | 334 | 1,019 | 870 | |
| Interest expense | -21 | -6 | -32 | -23 | |
| Other non-operating income, net | 6 | 6 | 3 | 13 | |
| Loss on sale of businesses | -5 | -37 | -17 | -47 | |
| Income before taxes | 365 | 297 | 973 | 813 | |
| Income tax expense | -77 | -71 | -235 | -196 | |
| Net income | 288 | 226 | 738 | 617 | |
| Net loss attributable to non-controlling interests | 3 | 1 | 9 | 5 | |
| Net income attributable to Xylem | 291 | 227 | 747 | 622 | |
| Earnings per share: | Basic | 1.25 | 0.93 | 3.15 | 2.56 |
| Earnings per share: | Diluted | 1.25 | 0.93 | 3.14 | 2.55 |
| Weighted average number of shares: | Basic | 232.7 | 243.5 | 237.3 | 243.3 |
| Weighted average number of shares: | Diluted | 233 | 244.1 | 237.7 | 243.9 |
Income Statement
($ Millions, except per share amounts)
| Q3 2026 – As Reported | Q3 2026 – Adjustments | Q3 2026 – Adjusted | Q3 2025 – As Reported | Q3 2025 – Adjustments | Q3 2025 – Adjusted | |
|---|---|---|---|---|---|---|
| Total Revenue | 2,201 | 2,201 | 2,268 | 2,268 | ||
| Operating Income | 385 | 43 | 428 | 334 | 95 | 429 |
| Operating Margin | 17.5 | 19.4 | 14.7 | 18.9 | ||
| Interest Expense | -21 | -21 | -6 | -6 | ||
| Other Non-Operating Income (Expense) | 6 | 6 | 6 | 6 | ||
| Gain/(Loss) from Sale of Business | -5 | 5 | -37 | 37 | ||
| Income before Taxes | 365 | 48 | 413 | 297 | 132 | 429 |
| Provision for Income Taxes | -77 | -3 | -80 | -71 | -26 | -97 |
| Net Income | 288 | 45 | 333 | 226 | 106 | 332 |
| Net Loss Attributable to Non-controlling Interests | 3 | 3 | 1 | 1 | ||
| Net Income Attributable to Xylem | 291 | 45 | 336 | 227 | 106 | 333 |
| Diluted Shares | 233 | 233 | 244.1 | 244.1 | ||
| Diluted EPS | 1.25 | 0.19 | 1.44 | 0.93 | 0.44 | 1.37 |
Income Statement
($ Millions)
| 2026 – Q1 | Q1 | 2026 – Q1 | Q1 | 2026 – Q2 | Q2 | 2026 – Q2 | Q2 | 2026 – Q3 | Q3 | 2026 – Q3 | Q3 | 2026 – Q4 | Q4 | 2026 – Total | Total | 2026 – Total | Total | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income attributable to Xylem | 193 | 263 | 291 | 747 | |||||||||||||||
| Net Income Margin | 9.1 | 11.3 | 13.2 | N/A | 11.2 | ||||||||||||||
| Depreciation | 65 | 65 | 65 | 195 | |||||||||||||||
| Amortization | 75 | 75 | 72 | 222 | |||||||||||||||
| Interest Expense (Income), net | -4 | 2 | 15 | 13 | |||||||||||||||
| Income Tax Expense | 55 | 103 | 77 | 235 | |||||||||||||||
| EBITDA | 384 | 508 | 520 | 1,412 | |||||||||||||||
| EBITDA Margin | 18.1 | 21.7 | 23.6 | N/A | 21.2 | ||||||||||||||
| Share-based Compensation | 13 | 12 | 14 | 39 | |||||||||||||||
| Restructuring & Realignment | 38 | 13 | 14 | 65 | |||||||||||||||
| Special Charges | 10 | -3 | -23 | -16 | |||||||||||||||
| Loss/(Gain) from sale of businesses | -4 | 16 | 5 | 17 | |||||||||||||||
| Loss attributable to non-controlling interest | -4 | -2 | -3 | -9 | |||||||||||||||
| Adjusted EBITDA | 437 | 544 | 527 | 1,508 | |||||||||||||||
| Revenue | 2,125 | 2,336 | 2,201 | 6,662 | |||||||||||||||
| Adjusted EBITDA Margin | 20.6 | 23.3 | 23.9 | N/A | 22.6 | ||||||||||||||
| 2025 | Net Income attributable to Xylem | 169 | 226 | 227 | 335 | 957 | |||||||||||||
| 2025 | Net Income Margin | 8.2 | 9.8 | 10 | 14 | 10.6 | |||||||||||||
| 2025 | Depreciation | 68 | 69 | 64 | 66 | 267 | |||||||||||||
| 2025 | Amortization | 77 | 76 | 78 | 77 | 308 | |||||||||||||
| 2025 | Interest Expense (Income), net | 3 | -1 | 2 | |||||||||||||||
| 2025 | Income Tax Expense | 50 | 75 | 71 | 35 | 231 | |||||||||||||
| 2025 | EBITDA | 364 | 449 | 440 | 512 | 1,765 | |||||||||||||
| 2025 | EBITDA Margin | 17.6 | 19.5 | 19.4 | 21.4 | 19.5 | |||||||||||||
| 2025 | Share-based Compensation | 12 | 13 | 12 | 16 | 53 | |||||||||||||
| 2025 | Restructuring & Realignment | 27 | 29 | 30 | 45 | 131 | |||||||||||||
| 2025 | Special Charges | 12 | 13 | 9 | 2 | 36 | |||||||||||||
| 2025 | Loss/(Gain) from sale of businesses | 10 | 37 | -16 | 31 | ||||||||||||||
| 2025 | Loss attributable to non-controlling interest | -2 | -2 | -1 | -2 | -7 | |||||||||||||
| 2025 | Adjusted EBITDA | 423 | 502 | 527 | 557 | 2,009 | |||||||||||||
| 2025 | Revenue | 2,069 | 2,301 | 2,268 | 2,397 | 9,035 | |||||||||||||
| 2025 | Adjusted EBITDA Margin | 20.4 | 21.8 | 23.2 | 23.2 | 22.2 |
Balance Sheet
(in millions)
| September 30, 2026 | December 31, 2025 | ||
|---|---|---|---|
| Current assets: | Cash and cash equivalents | 708 | 1,479 |
| Current assets: | Receivables, less allowances for discounts, returns and credit losses of $58 and $68 in 2026 and 2025, respectively | 1,965 | 1,759 |
| Current assets: | Inventories | 1,052 | 983 |
| Current assets: | Prepaid and other current assets | 227 | 244 |
| Current assets: | Assets held for sale | 176 |
Cash Flow
For the periods ended June 30, — (in millions)
| 2026 | 2025 | ||
|---|---|---|---|
| Net income | 738 | 617 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | Depreciation | 195 | 201 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Amortization | 222 | 231 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Share-based compensation | 39 | 37 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Restructuring and asset impairment charges | 50 | 70 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Loss from sale of businesses | 17 | 47 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Other, net | -32 | 3 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Payments for restructuring | -59 | -48 |
| Changes in assets and liabilities (net of acquisitions): | Changes in receivables | -201 | -113 |
| Changes in assets and liabilities (net of acquisitions): | Changes in inventories | -72 | -30 |
| Changes in assets and liabilities (net of acquisitions): | Changes in accounts payable | 29 | -45 |
| Changes in assets and liabilities (net of acquisitions): | Changes in accrued and deferred taxes | 14 | -12 |
| Changes in assets and liabilities (net of acquisitions): | Changes in long term receivables | -147 | -108 |
| Changes in assets and liabilities (net of acquisitions): | Other, net | -64 | -152 |
| Changes in assets and liabilities (net of acquisitions): | Net Cash – Operating activities | 729 | 698 |
| Investing Activities | Capital expenditures | -268 | -248 |
| Investing Activities | Acquisition of businesses, net of cash acquired | -425 | -113 |
| Investing Activities | Proceeds from sale of business, net of cash disposed | 95 | 48 |
| Investing Activities | Proceeds from the sale of property, plant and equipment | 12 | 15 |
| Investing Activities | Cash received from investments | 8 | 5 |
| Investing Activities | Cash paid for investments | -10 | -26 |
| Investing Activities | Cash paid for equity investments | -4 | -5 |
| Investing Activities | Cash paid for asset acquisition | -2 | -37 |
| Investing Activities | Cash received from cross-currency swaps | 39 | 31 |
| Investing Activities | Other, net | 1 | 1 |
| Investing Activities | Net Cash – Investing activities | -554 | -329 |
| Financing Activities | Short-term debt issued, net | 4 | 8 |
| Financing Activities | Short-term debt repaid | -5 | -7 |
| Financing Activities | Long-term debt issued, net | 990 | |
| Financing Activities | Long-term debt repaid, net | -10 | -60 |
| Financing Activities | Repurchase of common stock | -1,580 | -14 |
| Financing Activities | Proceeds from exercise of employee stock options | 3 | 11 |
| Financing Activities | Dividends paid | -307 | -293 |
| Financing Activities | Other, net | -30 | -27 |
| Financing Activities | Net Cash – Financing activities | -935 | -382 |
| Financing Activities | Effect of exchange rate changes on cash | -23 | 83 |
| Financing Activities | Increase in cash classified within assets held for sale | -11 | |
| Financing Activities | Decrease in cash classified within assets held for sale | 12 | 11 |
| Financing Activities | Changes in cash classified within assets held for sale | 12 | |
| Financing Activities | Net change in cash and cash equivalents | -771 | 70 |
| Financing Activities | Cash and cash equivalents at beginning of year | 1,479 | 1,121 |
| Financing Activities | Cash and cash equivalents at end of period | 708 | 1,191 |
| Cash paid during the period for: | Interest | 39 | 43 |
| Cash paid during the period for: | Income taxes (net of refunds received) | 221 | 208 |
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “contemplate,” “predict,” “forecast,” “likely,” “believe,” “target,” “goal,” “objective,” “will,” “could,” “would,” “should,” “potential,” “may” and similar expressions or their negative, may, but are not necessarily to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector demand and spending, interest rates, availability of funding to our customers, timing of customers’ capital spending and project deployments, inflation and governments' related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain, compete for, and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth and portfolio optimization actions, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, volatile weather events, or changing climate patterns; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; our level of indebtedness, including debt incurred to finance the pending Cornell Pump and Roper Pump acquisition; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other³ factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).
All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.⁴